Dopaminergic supersensitivity after neuroleptics: time-course and specificity

Muller, Pavel, Seeman, Philip·1978·Psychopharmacology

DOI 10.1007/bf00429171

Cited by (271)

Items 101–200 of 271

PRECLINICAL STUDY: Long‐term haloperidol treatment (but not risperidone) enhances addiction‐related behaviors in mice: role of dopamine D2 receptors
Rita C. Carvalho, Daniela Fukue Fukushiro, Daniel Corrêa Helfer, Donato Callegaro‐Filho, Thaís Fernanda Trombin, Lineane Helena Fernandes Zanlorenci, Leandro Sanday, Regina H. Silva, Roberto Frussa‐Filho · 2009 · Addiction Biology
Enhanced Neurobehavioral Effects of Cocaine With Chronic Neuroleptic Exposure in Rats
Therese A. Kosten · 1997 · Schizophrenia Bulletin
Chemical and Structural Changes in the Brain in Patients with Movement Disorder
Alan J. Cross, Timothy John Crow, Ian Nicol Ferrier, J. A. Johnson, Eve C. Johnstone, Frank Owen, David G. Cunningham Owens, Mark Poulter · 1985 · Psychopharmacology series
Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade
Paolo Barone, Ida Tucci, Sotirios Andreas Parashos, Thomas N. Chase · 1988 · European Journal of Pharmacology
THE USE OF THE SYNTHETIC PEPTIDES γ‐TYPE ENDORPHINS IN MENTALLY ILL PATIENTS
Jan M. van Ree, Wim M. A. Verhoeven, David de Wied, Herman M. van Praag · 1982 · Annals of the New York Academy of Sciences
Effects of repeated apomorphine and haloperidol treatments on subsequent behavioral sensitivity to apomorphine
Bruce A. Mattingly, James K. Rowlett · 1989 · Pharmacology Biochemistry and Behavior
CNS Dopamine Receptors
Ian Creese, Mark W. Hamblin, Stuart E. Leff, David R. Sibley · 1983 · Springer eBooks
Atypical antipsychotics—recent findings and new perspectives
John A. Lowe III, Thomas Seeger, Fredric J. Vinick · 1988 · Medicinal Research Reviews
Behavioral and biochemical studies of dopamine receptor sensitivity in differentially housed mice
Carole A. Wilmot, Christina Vander Wende, Marie T. Spoerlein · 1986 · Psychopharmacology
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake
K. Murugaiah, Simon Fleminger, Andreas E. Theodorou, Peter G. Jenner, C. DAVID MARSDEN · 1983 · Biochemical Pharmacology
Emergence of apomorphine-induced ‘vacuous chewing’ during 6 months continuous treatment with fluphenazine decanoate
John L. Waddington, Stephen J. Gamble · 1980 · European Journal of Pharmacology
Dopamine D2Highreceptors moderately elevated by bifeprunox and aripiprazole
Philip M. Seeman · 2008 · Synapse
Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics
John G. Csernansky, Elisabeth S. Prosser, Jonathan Kaplan, Elizabeth Mahler, Philip A. Berger, Leo E. Hollister · 1986 · Biological Psychiatry
Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: Relationship to dose and drug
James Alan Severson, H. Eugene Robinson, George M. Simpson · 1984 · Psychopharmacology
A permanent dopamine receptor up-regulation in the ovariectomized rat
John H. Gordon, Jeremy Z. Fields · 1989 · Pharmacology Biochemistry and Behavior
Serotonin receptor blocking effect of SCH 23390
Maria Bijak, Antoni Śmia⌈owski · 1989 · Pharmacology Biochemistry and Behavior
Denervation supersensitivity to 5-hydroxytryptamine in the rat spinal cord is not due to the absence of 5-hydroxytryptamine
Louis E. Tremblay, Paul J. Bédard, Ronald Maheux, Thérèse Di Paolo · 1985 · Brain Research
Review of Antipsychotic Medication Administration: A Proposal of Intermittent Dosing
Roger A. Boshes, Theo C. Manschreck · 2002 · Schizophrenia Bulletin
Receptor changes during chronic dopaminergic stimulation
Peter G. Jenner, Sue Boyce, C. DAVID MARSDEN · 1988 · Springer eBooks
Effects of the Dopamine D2 Selective Receptor Antagonist Remoxipride on Dopamine Turnover in the Rat Brain after Acute and Repeated Administration
Olle Magnusson, Bodil Mohringe, Gun Thorell, Desmond M. Lake‐Bakaar · 1987 · Pharmacology & Toxicology
Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium
Thomas Seeger, Eliot L. Gardner, WagnerH. Bridger · 1981 · Brain Research
Drug discrimination in rats: Evidence for amphetamine-like cue state following chronic haloperidol
Robert J. Barrett, Larry R. Steranka · 1983 · Pharmacology Biochemistry and Behavior
Chronic administration of three neuroleptics: Effects of behavioral supersensitivity mediated by two different brain regions in the rat
Ronnie Halperin, Jeanine Guérin, Kenneth L. Davis · 1983 · Life Sciences
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology and tardive dyskinesia
Franz Müller-Spahn, Manfred Ackenheil, Margot Albus, G. May, Dieter Naber, D. Welter, Karl Zander · 1984 · Psychopharmacology
Amphetamine-haloperidol discrimination: Effects of chronic drug treatment
Marianne Haenlein, William F. Caul, Robert J. Barrett · 1985 · Pharmacology Biochemistry and Behavior
Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics
Ronnie Halperin, John J. Guerin, Kenneth L. Davis · 1989 · Psychopharmacology
Enhancement of avoidance-suppressing effect after repeated administration of haloperidol and serum haloperidol in rats
Tetsu Hayashi, Sakutaro Tadokoro, Hisakuni Hashimoto, Mitsuyoshi Nakashima · 1982 · Pharmacology Biochemistry and Behavior
Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat
Guy Debonnel, Pierrette Gaudreau, Rémi Quirion, Claude de Montigny · 1990 · Journal of Neuroscience
Alterations in Neurotransmitter Receptor Binding in Discrete Areas of the Copper‐Deficient Rat Brain
Daniel J. Feller, B. L. O’Dell, Dan Bylund · 1982 · Journal of Neurochemistry
Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice
Patrick K. Randall, James Alan Severson, Stanley M. Hurd, William O. McClure · 1985 · Brain Research
Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding
R. Christopher Pierce, James K. Rowlett, M.T. Bard, George V. Rebec · 1991 · Neuroscience
Sequelae of 6 months continuous administration of cis(Z)- and trans(E)-flupenthixol in the rat
John L. Waddington, Stephen J. Gamble, Rachel C. Bourne · 1981 · European Journal of Pharmacology
Selective increase ofα1-adrenoceptors and muscarinic cholinergic receptors in rat cerebral cortex after chronic haloperidol
Jorge Horacio Pazo, M. Levi de Stein, Diana Alicia Jerusalinsky, María Laura Novas, Sonia Raskovsky, Omar R. Tumilasci, Jorge Horacio Medina, Eduardo D. P. De Robertis · 1987 · Brain Research
Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin
Martin Valchář, Jiřina Metyšová, J. Chlebounová, Antonín Dlabač · 1982 · Psychopharmacology
Influence of age on the effects of chronic fluphenazine on receptor binding in rat brain
Chandra H. Misra, Harnath S. Shelat, Robert C. Smith · 1981 · European Journal of Pharmacology
Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain
Zbigniew Stanislaw Herman, Małgorzata Huzarska, Krystyna Kmieciak-Kołada, J. Kowalski · 1991 · Psychopharmacology
Substantia nigra 6‐hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats
Changiz Geula, John T. Slevin · 1989 · Synapse
Antinociception following 1,3,-di-o-tolylguanidine, a selective σ receptor ligand
Jeffrey S. Mogil, Wendy F. Sternberg, Robert N. Pechnick, John C. Liebeskind, Benjamin Kest · 1995 · Pharmacology Biochemistry and Behavior
Functional aging of the nigro-striatal system
Patrick K. Randall · 1980 · Peptides
Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials
Jonathan Lockwood, Gary J. Remington · 2015 · Expert Opinion on Emerging Drugs
Behavioral pharmacology of orofacial movement disorders
Noriaki Koshikawa, Satoshi Fujita, Kazunori Adachi · 2011 · International review of neurobiology
Early-life risperidone administration alters maternal–offspring interactions and juvenile play fighting
Matthew A. Gannon, Clifford J. Brown, Rachel M. Stevens, Molly S. Griffith, Cécile A. Marczinski, Mark E. Bardgett · 2015 · Pharmacology Biochemistry and Behavior
The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia
Michael Davidson · 2018 · Dialogues in Clinical Neuroscience
Differential effects of ageing on distinct features of apomorphine stereotypy in the adult rat
John L. Waddington, Stephen J. Gamble · 1980 · Neuroscience Letters
Nitric oxide synthesis inhibition attenuates haloperidol-induced supersensitivity.
Cindy M. Pudiak, Michael A. Bozarth · 1997 · PubMed Central
D2 Dopamine Antisense RNA Expression Vector, Unlike Haloperidol, Produces Long-term Inhibition of D2Dopamine-Mediated Behaviors without Causing Up-regulation of D2 Dopamine Receptors
Genoveva Davidkova, Long-Wu Zhou, Mark Morabito, S P Zhang, Benjamin Weiss · 1998 · Journal of Pharmacology and Experimental Therapeutics
Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine
Alexander Campbell, Ross J. Baldessarini, John L. Neumeyer · 1993 · Psychopharmacology
During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated
R.G. Dyer, K. Murugaiah, A. Theodorou, Angela Clow, Peter G. Jenner, C. DAVID MARSDEN · 1981 · Life Sciences
Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain
Beata Karolewicz, Lucyna Antkiewicz‐Michaluk, Jerzy Michaluk, Jerzy Vetulani · 1996 · European Journal of Pharmacology
Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity
John H. Gordon, J. Kirk Clopton, J.C. Curtin, William C. Koller · 1987 · Pharmacology Biochemistry and Behavior
Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels
Lucyna Antkiewicz‐Michaluk, Beata Karolewicz, Jerzy Michaluk, Jerzy Vetulani · 1995 · European Journal of Pharmacology
Fractionation of the cataleptic bracing response in rats
Sergio Marcello Pellis, Yu-Chien Chen, Philip Teitelbaum · 1985 · Physiology & Behavior
Extended mepyramine treatment and histamine H1-receptors in guinea-pig brain
Stephen John Hill, C. Robin Hiley, J.M. Young · 1981 · European Journal of Pharmacology
Increased amphetamine potency following chronic naltrexone administration in rats
Shimon Amir, Richard Blair, Zalman Amit · 1979 · Life Sciences
Variability and the Dopamine Hypothesis of Schizophrenia
John G. Csernansky, Cynthia A. Holman, Leo E. Hollister · 1983 · Schizophrenia Bulletin
Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference
Mark E. Bardgett, Tyler Downnen, Casey Crane, Emily C. Baltes Thompson, Brittany T Muncie, Sara A. Steffen, Justin R. Yates, James R. Pauly · 2020 · Neuropharmacology
Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors
Elisabeth S. Prosser, John G. Csernansky, Leo E. Hollister · 1988 · Life Sciences
Emergence of Oral and Locomotor Activity in Chronic Haloperidol-Treated Rats Following Cortical N-Methyl-d-Aspartate Stimulation
Jeffrey W. Grimm, Paul J. Kruzich, R.E. See · 1998 · Pharmacology Biochemistry and Behavior
The effect of haloperidol feeding on dopamine receptor number in ten mouse strains
Robert Haim Belmaker, Jacob Bannet, Ester Brecher‐Fride, Joseph Yanai, Richard P. Ebstein · 1981 · Clinical Genetics
Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors
M. Y. -T. Globus, Bernard Lerer, R. Hamburger, Robert Haim Belmaker · 1981 · Neuropharmacology
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence
Michael Davidson, William T. Carpenter · 2023 · Schizophrenia Bulletin
Dopamine turnover and glutamate decarboxylase activity in the rat brain after acute and chronic treatment with raclopride, a dopamine D2-selective antagonist
Christopher John Fowler, O. Magnusson, Gun Thorell, Bodil Mohringe, R.-B. Huang · 1987 · Neuropharmacology
Effect of chronic apomorphine on the development of denervation supersensitivity
Marc M. Robin, Christian Forler, Michael G. Palfreyman · 1985 · Pharmacology Biochemistry and Behavior
411B: A Monoclonal Postsynaptic Marker for Modulations of Synaptic Connectivity in the Rat Brain
B. Loessner, Sarah Bullock, Steven P. R. Rose · 1988 · Journal of Neurochemistry
Spontaneous activity and apomorphine stereotypy during and after withdrawal from $$3{\raise0.5ex\hbox{$\scriptstyle 1$}\kern-0.1em/\kern-0.15em\lower0.25ex\hbox{$\scriptstyle 2$}}$$ months continuous administration of haloperidol: Some methodological issues
John L. Waddington, Stephen J. Gamble · 1980 · Psychopharmacology
Neuroleptic Drugs in the Treatment of Acute Psychosis: How Much Do We Really Know?
Bruce M. Cohen · 1988 · Springer eBooks
Chronic Treatment with Antipsychotic Drugs Does not Alter G Protein α or β Subunit Levels in Rat Brain
Emanuel Meller, Karen Bohmaker · 1996 · Neuropharmacology
Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta
Katsuo Kamata, Tsutomu Kameyama, Shigeru Okuyama, Sanae Hashimoto, Hironaka Aihara · 1986 · Brain Research
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Patricia Gassó, Natàlia Rodríguez, Albert Martínez-Pinteño, Gisela Mezquida, M. Ribeiro, Javier González‐Peñas, Eric P. Zorrilla, Laura Martínez-Sadurní, Roberto Rodríguez–Jiménez, Iluminada Corripio et al. · 2021 · Translational Psychiatry
Delayed yet persistent effects of daily risperidone on activity in developing rats
Rachel M. Stevens, Matthew A. Gannon, Molly S. Griffith, Mark E. Bardgett · 2016 · Behavioural Pharmacology
Dopaminergic dysregulation in schizophrenia: A target for new drugs
Kenneth L. Davis, Michael Fiori, Bonnie M. Davis, Richard C. Mohs, Thomas Horvath, Michael Davidson · 1986 · Drug Development Research
Behavioural and Biochemical Effects of Subchronic Treatment with Raclopride in the Rat: Tolerance and Brain Monoamine Receptor Sensitivity
Sven Ahlénius, Evalena Ericson, Kerstin Högberg, Agneta Wijkström · 1991 · Pharmacology & Toxicology
Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of wistar rats: A genuine model of basal ganglia dysfunction?
Lechosław Turski, Michael Schwarz, K.‐H. Sontag · 1984 · Behavioural Brain Research
Pharmacological Studies on the Interrelation between the Dopaminergic, GABAergic and Opioid Peptidergic Systems in the Central Nervous System of the Rat
Katsuo Kamata · 1987 · The Japanese Journal of Pharmacology
Modification of Antinociceptive Action of Morphine by Dopamine Agonist and Antagonist in Mice
Katsuo Kamata, Kunihiko OGAWA, Tsutomu Kameyama · 1985 · The Japanese Journal of Pharmacology
Dopamine Receptor Changes During Chronic Drug Administration
Andrew James Greenshaw, Glen B. Baker, Thomas B. Wishart · 1989 · Humana Press eBooks
Pressure-induced disorders in neurotransmission and spontaneous behavior in rats: An animal model of psychosis
Jacques H. Abraini, Marc Ansseau, Taoufiq Fechtali · 1993 · Biological Psychiatry
Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum
Emanuel Meller, Eitan Friedman · 1981 · European Journal of Pharmacology
Central nervous system receptors in neuropsychiatric disorders
Gabor Kato, Thomas A. Ban · 1982 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Heart Rate, Blood Pressure Regulation and Neurotransmitter Balance in Tourette's Syndrome
E. L. Schelkunov, O G Kenunen, Pushkov Vv, R.A. CHARITONOV · 1986 · Journal of the American Academy of Child Psychiatry
DOPAMINE RECEPTORS IN BRAIN
Philip M. Seeman · 1984 · Elsevier eBooks
Chronic administration of SCH 23390 enhances spontaneous searching and locomotor activity of rats. An open field study
A Smiałowski · 1989 · Behavioural Brain Research
Tics Status
Perminder Singh Sachdev, Kit-Yun Chee, Andrew Wilson · 1996 · Australian & New Zealand Journal of Psychiatry
Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain
Yoshihide Imazu, Kiyofumi Kobayashi, Toshikiyo Shohmori · 1989 · Neurochemical Research
A dietary haloperidol regimen for inducing dopamine receptor supersensitivity in rats
Joseph M. Frey · 1987 · Pharmacology Biochemistry and Behavior
Chronic fluphenazine treatment modifies circadian rhythms of neurotransmitter receptor binding in rat brain
Dieter Naber, Anna Wirz‐Justice, Marian S. Kafka · 1982 · Journal of Neural Transmission
Adaptive Alterations in Receptor Mediated Processes and their Implications for Some Mental Disorders
Kenneth A. Bonnet · 1979 · Advances in experimental medicine and biology
Functional supersensitivity of the hippocampal dopaminergic system after prolonged treatment with haloperidol
Maria Bijak, A Smiałowski · 1989 · Pharmacology Biochemistry and Behavior
Prolonged treatment with the GABA agonist THIP increases dopamine receptor binding more than it changes dopaminergic behaviour in mice
Anne Vibeke Christensen, John Hyttel · 1981 · Drug Development Research
Age affects dopamine receptor changes during chronic administration of fluphenazine
Chandra H. Misra, Harnath S. Shelat, Robert C. Smith · 1982 · European Journal of Pharmacology
Reduction of dopaminergic supersensitivity by a single dose of amphetamine
John L. Haracz, Liang‐Fu Tseng · 1980 · Naunyn-Schmiedeberg s Archives of Pharmacology
D2-Dopaminergic Agonist Quinpirole and 8-Bromo-Camp have Opposite Effects on Goα Gtp-Binding Protein mRNA without Changing D2 Dopamine Receptor mRNA Levees in Striatal Neurones in Primary Culture
Marion Maus, Philippe Vernier, Olivier Valdenaire, Vincent Homburger, Joël Bockaert, Jacques Glowinski, Jacques J. Mallet · 1993 · Journal of Receptor Research
Alterations in mice dopamine receptor characteristics after early exposure to phenobarbital
Carmela Iser-Strenger, Joseph Yanai · 1986 · Developmental Brain Research
Resistance to barbiturate is changed by developmental alteration of dopamine receptor sensitivity
Joseph Yanai, Rachelle HB Fishman · 1984 · International Journal of Developmental Neuroscience
Effect of chronic administration of methamphetamine on the responsiveness of substantia nigra zona reticulata neurons to GABA or a GABA agonist in rats
Katsuo Kamata, Tsutomu Kameyama · 1986 · Naunyn-Schmiedeberg s Archives of Pharmacology
The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice
Yoshikatu Masuda, Shin Murai, Hirohisa Saito, E. Abe, Hideyo Fujiwara, Isohachi Kohori, Tadanobu Itoh · 1991 · Neuropharmacology
Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat
Ann Marie Szczepanik, Carole A. Wilmot · 1997 · Neuroscience Letters
Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
Katsuo Kamata, KUNIHIKO OGAWA, Shigeki Noma, Tsutomu Kameyama · 1986 · Journal of Pharmacobio-Dynamics
Haloperidol-induced supersensitivity to the discrimination of apomorphine
Martin Schechter · 1981 · European Journal of Pharmacology
Cyclo (Leu-Gly) + haloperidol: Effects on dopamine receptors and conditioned avoidance responding
Andrew Bean, Robert J. Elgin, Direese M. Cooper, Gregory E. Martin · 1987 · Peptides